Open Access Articles- Top Results for Cyprazepam


Systematic (IUPAC) name
Clinical data
  •  ?
Pharmacokinetic data
Bioavailability ?
Metabolism Hepatic
Half-life ?
Excretion Renal
15687-07-7 7pxY
PubChem CID 27452
ChemSpider 16736916 7pxY
UNII 933N61G4SL 7pxY
KEGG D03631 7pxY
ChEMBL CHEMBL2104165 7pxN
Chemical data
Formula C19H18ClN3O
339.819 g/mol
 14pxN (what is this?)  (verify)

Cyprazepam[1] is a drug which is a sedative-hypnotic benzodiazepine derivative.[2][3][4][5] It has anxiolytic properties,[6] and presumably also has hypnotic, skeletal muscle relaxant, anticonvulsant and amnestic properties.

See also


  1. US Patent 3138586
  2. Herbert Oelschläger; Doris Martienssen; F. Belal (22 September 2006). "Ring Contraction of 1,4-Benzodiazepines to 3,4-Dihydroquinazolines During Macro Scale Reduction (Example 5: Cyprazepam)". Archiv der Pharmazie (Wiley Interscience) 325 (8): 503–507. ISSN 0365-6233. doi:10.1002/ardp.19923250810. 
  3. Bradley Matthews; Shashoua Victor; Webb Nigel; Swindell Charles (13 October 2004). "DHA-pharmaceutical agent conjugates - European Patent Application EP1466628". Patents online. Retrieved 19 September 2009. 
  4. "Harmonized Tariff Schedule of the United States (2009) - Supplement 1 - PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE" (PDF). USA: United States International Trade Commission. 2009. Retrieved 19 September 2009. 
  5. E. W. Schafer; W. A. Bowles, Jr; J. Hurlbut (1983). "The Acute Oral Toxicity, Repellency, and Hazard Potential of 998 Chemicals to One or More Species of Wild and Domestic Birds" (PDF). Arch. Environm. Contam. Toxicol (USA) 12 (3): 355–382. PMID 6882015. doi:10.1007/BF01059413. Retrieved 19 September 2009. 
  6. World Health Organisation (2006). "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances" (PDF). USA: Minstry of health, Syria. Retrieved 19 September 2009. [dead link]

Lua error in package.lua at line 80: module 'Module:Buffer' not found.